Patient Perceptions of Illness Identity in Cancer Clinical Trial Decision-Making

Authors

Angela L. Palmer-Wackerly, University of Nebraska-LincolnFollow
Phokeng M. Dailey, The Ohio State University
Jessica L. Krok-Schoen, The Ohio State University;
Nancy D. Rhodes, Michigan State University
Janice L. Krieger, University of Florida

ORCID IDs

Angela L. Palmer-Wackerly http://orcid.org/0000-0001-8384-5225

Jessica L. Krok-Schoen http://orcid.org/0000-0003-2484-5887

Date of this Version

2018

Citation

HEALTH COMMUNICATION 2018, VOL. 33, NO. 8, 1045–1054

doi 10.1080/10410236.2017.1331189

PMID: 28622019

PMCID: PMC6145173 [Available on 2019-08-01]

Comments

Copyright © 2017 Taylor & Francis Group, LLC

A free-access version of this paper will become available from PubMed Central on August 1, 2019.

A subscription-required version is available from the publisher here: https://doi.org/10.1080/10410236.2017.1331189

Abstract

When patients are diagnosed with cancer, they begin to negotiate their illness identity in relation to their past and future selves, their relationships, and their group memberships. Thus, how patients view their cancer in relation to their other identities may affect how and why they make particular decisions about treatment options. Using the Communication Theory of Identity (CTI), the current study explores: (1) how and why illness identity is framed across identity layers in relation to one particular cancer treatment: participation in a cancer clinical trial (CT); and (2) how and why patients experience identity conflicts while making their treatment decisions. Semi-structured, in-depth interviews were analyzed for 46 cancer patients who were offered a CT. Results of a grounded theory analysis indicated that patients expressed separate identity frames (e.g., personal, relational, and communal), aligned identity frames (e.g., personal and communal), and identity conflicts (e.g., personal-personal). This study theoretically shows how and why patient illness identity relates to cancer treatment decision-making as well as how and why patients relate (and conflict) with the cancer communal identity frame. Practical implications include how healthcare providers and family members can support patient decision-making through awareness of and accommodating to identity shifts.